Perceptions and acceptability of microsampling for remote monitoring in patients with plasma cell dyscrasias

In this webinar, we discuss the importance of involving patients in our research and the valuable insight we have been able to gain.

Multiple myeloma is categorized as a relapsing-remitting blood cancer and requires frequent blood tests. Microsampling introduces a self-administered, blood sampling technique that has potential to revolutionize multiple myeloma monitoring.

In this presentation, we discuss how we incorporated patient and public involvement (PPI) into our study. PPI contributors aided in the development of our research protocol and questionnaire, and reviewed patient-facing documents. Feedback from these representatives proved to be insightful and the consensus was that microsampling would be a welcome addition to the routine clinical care of multiple myeloma.

Of interest to:

  • Clinical researchers and trials teams aiming to incorporate Patient and Public Involvement (PPI) in research processes
  • Healthcare providers seeking to integrate microsampling methods within patient pathways
  • Developers of microsampling tools looking to understand patient perspectives
  • Members of the public and/or patients interested in getting involved in research​​​​​​​​​​​

​​What you will learn

  • The importance of working collaboratively with patients through various stages of a trial
  • How to run focus groups for patient and public engagement
  • Myeloma patient insight to current patient monitoring pathways
  • Myeloma patient perspectives and satisfaction of remote monitoring

Speakers

Nithya Paranthaman

Senior Scientific Officer, The Royal Marsden Hospital

Nithya Paranthaman is currently a Senior Scientific Officer at The Royal Marsden Hospital (RMH; Sutton, UK). Nithya’s research focuses on developing remote patient monitoring schemes in cancer pathways. She completed her PhD at the Institute of Cancer Research (ICR; Sutton, UK) in 2023. Her PhD project included method development and optimization of microsampling tools to monitor disease status in multiple myeloma patients. Prior to joining the RMH, she worked at Sanofi Genzyme (MA, USA) and Novartis (NJ, USA). Her research interests lie at the intersection of clinical research and patient-centricity.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with